Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
CKNN - As of  05/16/24, 08:21:51 AM:   18 Insider Transactions.

Sector: Unknown    Industry: Business Equipment
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for CKNN

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-06-10 15:06:30.0 ARCA biopharma ABIO Altium Capital Management LP 9.99% view
B 2020-06-01 14:07:29.0 ARCA biopharma ABIO SABBY MANAGEMENT 9.99% view
B 2020-02-12 19:28:21.0 ARCA biopharma ABIO RENAISSANCE TECHNOLOGIES LLC 8.94% view
S 2020-01-24 08:01:14.0 ARCA biopharma ABIO Tekla Capital Management LLC 2.3% view
B 2019-02-12 13:52:02.0 ARCA biopharma ABIO RENAISSANCE TECHNOLOGIES LLC 5.88% view
S 2019-02-12 09:04:26.0 ARCA biopharma ABIO Tekla Capital Management LLC 5.8% view
S 2018-03-08 11:53:51.0 ARCA biopharma ABIO FRANKLIN RESOURCES INC 4.0% view
S 2018-03-05 15:22:30.0 ARCA biopharma ABIO Growth Equity Opportunities IV n/a view
S 2018-02-14 17:08:52.0 ARCA biopharma ABIO RA CAPITAL MANAGEMENT 2.7% view
S 2018-02-13 19:26:10.0 ARCA biopharma ABIO VENROCK HEALTHCARE CAPITAL PARTNERS LP 17.4% view
S 2018-02-12 15:24:50.0 ARCA biopharma ABIO Tekla Capital Management LLC 6.9% view
S 2018-02-05 17:14:14.0 ARCA biopharma ABIO FRANKLIN RESOURCES INC 13.9% view
S 2018-01-04 11:18:23.0 ARCA biopharma ABIO SABBY MANAGEMENT 4.75% view
S 2017-02-13 11:44:54.0 ARCA biopharma ABIO Tekla Capital Management LLC 8.9% view
B 2016-02-16 10:32:05.0 ARCA biopharma ABIO VENROCK HEALTHCARE CAPITAL PARTNERS LP 19.9% view
B 2016-02-12 07:13:21.0 ARCA biopharma ABIO Tekla Capital Management LLC 9.0% view
B 2016-01-08 12:14:28.0 ARCA biopharma ABIO FRANKLIN RESOURCES INC 17.9% view
S 2016-01-06 14:37:24.0 ARCA biopharma ABIO SABBY MANAGEMENT 5.06% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.